Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03363113

Acronym

rétroBODOM

Enrollment

240

Registered

2017-12-06

Start date

2016-01-01

Completion date

2016-07-12

Last updated

2017-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonia; Orofacial

Brief summary

Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of patients medical charts

Interventions

DRUGBotulinum Toxins

Injection of botulinum toxin in the muscles affected by oromandibular dystonia

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient suffering from oromandibular dystonia * Medical follow up in the Fondation Ophtalmologique Rothschild (Paris) * Treatment by at least one session of botulinum toxin injection

Exclusion criteria

* Patient cannot assess symptoms improvement using a Likert scale

Design outcomes

Primary

Measure	Time frame	Description
Clinical improvement score	Two months	Likert scale for the assessment of the clinical improvement after treatment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026